Skip to main content Skip to accessibility
This website is not compatible with your web browser. You should install a newer browser. If you live in Jersey and need help upgrading call the States of Jersey web team on 440099.
Government of Jerseygov.je

Information and public services for the Island of Jersey

L'înformâtion et les sèrvices publyis pouor I'Île dé Jèrri

  • Choose the service you want to log in to:

  • gov.je

    Update your notification preferences

  • one.gov.je

    Access government services

  • CAESAR

    Clear goods through customs or claim relief

  • Talentlink

    View or update your States of Jersey job application

Prescribed List (Jersey): Changes as of 1 April 2011

A formal published “Ministerial Decision” is required as a record of the decision of a Minister (or an Assistant Minister where they have delegated authority) as they exercise their responsibilities and powers.

Ministers are elected by the States Assembly and have legal responsibilities and powers as “corporation sole” under the States of Jersey Law 2005 by virtue of their office and in their areas of responsibility, including entering into agreements, and under any legislation conferring on them powers.

An accurate record of “Ministerial Decisions” is vital to effective governance, including:

  • demonstrating that good governance, and clear lines of accountability and authority, are in place around decisions-making – including the reasons and basis on which a decision is made, and the action required to implement a decision

  • providing a record of decisions and actions that will be available for examination by States Members, and Panels and Committees of the States Assembly; the public, organisations, and the media; and as a historical record and point of reference for the conduct of public affairs

Ministers are individually accountable to the States Assembly, including for the actions of the departments and agencies which discharge their responsibilities.

The Freedom of Information Law (Jersey) Law 2011 is used as a guide when determining what information is be published. While there is a presumption toward publication to support of transparency and accountability, detailed information may not be published if, for example, it would constitute a breach of data protection, or disclosure would prejudice commercial interest.

A decision made 18 February 2011.

Decision Reference: MD-S-2011-0006

Decision Summary Title :

DS -Prescribed List (Jersey) 1 April 2011

Date of Decision Summary:

9 February 2011

Decision Summary Author:

Policy Principal

Decision Summary:

Public or Exempt?

Public

Type of Report:

Oral or Written?

Written

Person Giving

Oral Report:

N/A

Written Report

Title :

WR - Prescribed List (Jersey) 1 April 2011

Date of Written Report:

9 February 2011

Written Report Author:

Policy Principal

Written Report :

Public or Exempt?

Public

Subject:

Changes to be made to the Prescribed List (Jersey) as at 1 April 2011

Decision(s): The Minister approved the changes to the Prescribed List (Jersey) as recommended by the Pharmaceutical Benefit Advisory Committee from the meeting held on 18 January 2011.

 

To be included from 1 April 2011 as green items:

Duloxetine (as hydrochloride) capsules 30mg; 60mg (Cymbalta brand only)

Nortriptyline tablets 10mg, 25mg

Pregabalin capsules  (all strengths) classification change  to green status

Zanamivir dry powder for inhalation 5mg/dose

Dioralyte oral powder sachets

Liquifilm Tears eye drops (preservative free) containing polyvinyl alcohol   1.4%, povidone 0.6% per 0.4mL unit dose

Sodium valproate modified-release (Episenta brand) capsules 150mg, 300mg; granules 500mg/sachet, 1g/sachet

Tramadol modified-release capsules 100mg, 150mg, 200mg

Oseltamivir capsules 30mg, 45mg, 75mg; suspension 60mg/5Ml

 

To be included as amber items (for initiation/stabilisation in secondary care before transfer to primary care)

Exenatide injection 250mcg/mL; 5mcg/dose pre-filled pen. 10mcg/dose pre-filled pen

Liraglutide injection 6mg/mL 2x3mL pre-filled pen, 3x3mL pre-filled pen

Saxagliptin tablets 5mg

Sitagliptin tablets 100mg; Sitagliptin/metformin tablets 50mg/1000mg

Vildagliptin tablets 50mg; vildagliptin/metformin tablets 50/850mg, 50/1000mg

 

To be included as amber items (subject to shared care protocols)

Dronedarone tablets 400mg

Ropinirole modified-release tablets 2mg, 4mg, 8mg

 

To give notice that the following items be deleted  from 1 July 2011

Tramadol modified –release tablets (all strengths)

Reason(s) for Decision:

The Pharmaceutical Benefit Advisory Committee met on 18 January 2011 and proposed the recommended changes to the Prescribed List (Jersey), effective from 1 April 2011. The changes represent best value amendments for approved medicines and ensure that General Practitioners have the choice available to them of modern, safe and effective medicines.

Resource Implications:

The additions represent a cost to the fund of approximately £115,500 per annum.

Action required:

Policy Principal to issue public notice listing amendments and notify all approved medical practitioners and approved contractors.

Signature:

 

 

Position:

Minister

 

Date Signed:

 

 

Date of Decision (If different from Date Signed):

 

 

Back to top
rating button